Clinical Trials Sponsored by Care Partners

Total 6088 results

Mayo Clinic
PSC Partners Seeking a Cure

Completed

A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis

United States
Manistee Partners

Unknown

Topical Bimatoprost in the Treatment of Migraine

Migraine Disorders | Headache Disorders

United States
Open Innovation Partners, Inc.
Open Innovation Partners

Suspended

TR1801-ADC in Patients With Tumors That Express c-Met

Unspecified Adult Solid Tumor, Protocol Specific

United States
Radboud University Medical Center
PICASSO: Partners in Care Solutions for COPD

Completed

Monitoring Asthma and COPD in Primary Care (Monaco)

Lung Diseases, Obstructive | Asthma

Netherlands
Radboud University Medical Center
PICASSO: Partners in Care Solutions for COPD

Completed

Secondary Prevention of Problems in Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | Health Status

Netherlands
Molecular Partners AG

Recruiting

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia | Acute | Relapsed | Myeloid

Netherlands, France, Lithuania, Switzerland
Tetra Discovery Partners

Recruiting

A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Fragile X Syndrome

United States
Molecular Partners AG

Terminated

MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

EGFR-mutated NSCLC (Disorder)

United States
Molecular Partners AG

Completed

Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

France
Molecular Partners AG

Terminated

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

COVID-19

United Kingdom
Molecular Partners AG

Completed

First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors

Neoplasms

Germany, Switzerland, United Kingdom
Tetra Discovery Partners

Withdrawn

A Phase 1, Open-Label, PET Study of T2310 & BPN14770

To Determine Brain Target Occupancy of BPN14770

United States
Tetra Discovery Partners

Completed

A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome

Fragile X Syndrome | Fra(X) Syndrome | FXS

United States
Tetra Discovery Partners

Completed

Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

Alzheimer Disease

United States
A.A. Partners, LLC

Unknown

3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (3-D-TEBE)

Bone Defects

Ukraine
A.A. Partners, LLC

Unknown

Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) (ADSCs-BWs)

Second- or Third-degree Burns

Ukraine
Care Partners
Oregon Health and Science University; OHSU Knight Cancer Institute

Unknown

Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice (SFPRT)

Cancer Metastatic

United States
Molecular Partners AG

Completed

Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients

Covid19

Netherlands
Molecular Partners AG

Completed

A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma in Relapse

Poland, Italy, Germany, Denmark, Czechia, Austria
Tetra Discovery Partners

Unknown

Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects

Alzheimer's Disease

United States
Partners in Health

Unknown

Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3) (SHARED3)

Hepatitis C, Chronic

Rwanda
Molecular Partners AG

Completed

First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients

Neoplasms

Switzerland, Spain, United Kingdom
Tetra Discovery Partners

Completed

BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

Alzheimer's Disease

United States
Tetra Discovery Partners

Recruiting

A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Fragile X Syndrome

United States
Cardio Surgical Partners

Recruiting

Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

SCS

United States
Molecular Partners AG

Terminated

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Advanced Malignant Solid Tumor

Netherlands, France
Tetra Discovery Partners

Enrolling by invitation

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Fragile X Syndrome

United States
Partners in Health

Completed

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World (SHARED)

Chronic Hepatitis C

Rwanda
Tetra Discovery Partners

Completed

A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects

Alzheimer's Disease

United States
Cereal Partners Worldwide

Completed

Effects of Whole Grain on Weight Maintenance

Body Weight | Abdominal Fat

France
Rare Partners srl Impresa Sociale
Università degli Studi di Ferrara

Completed

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (SIRTHALACLIN)

Beta-Thalassemia

Italy
Nuvectra
Bright Research Partners

Terminated

Algovita Spinal Cord Stimulation System Hi-Fi Study

Chronic Pain

United States
ETOP IBCSG Partners Foundation

Completed

TRial on the Endocrine Activity of Neoadjuvant Degarelix (TREND)

Breast Cancer Invasive Nos

Italy
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema

Diabetic Macular Edema

United States
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Wet Age-Related Macular Degeneration

Switzerland, France, Czech Republic
Reproductive Partners Medical Group

Terminated

Effect of Omega 3 Fats on Sperm Quality and Sexual Function

Infertility

United States
ETOP IBCSG Partners Foundation

Completed

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer (12-93)

Breast Cancer

Switzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
ETOP IBCSG Partners Foundation

Completed

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer (10-93)

Breast Cancer

Switzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
ETOP IBCSG Partners Foundation

Withdrawn

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Breast Cancer | Osteoporosis

Switzerland
Infraredx
Bright Research Partners

Completed

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)

Coronary Stenosis | Coronary Artery Stenosis | In-stent Restenosis

United States
Duke University
Reinvestment Partners

Completed

Durham Healthy Breathing in Healthy Homes Project (DHBHH)

Poor Asthma Control

United States
ETOP IBCSG Partners Foundation

Completed

Afatinib in NSCLC With HER2 Mutation (NICHE)

NSCLC

Switzerland, Germany, Spain, Netherlands
ETOP IBCSG Partners Foundation

Completed

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 (SOFT-EST)

Breast Cancer

Spain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
ETOP IBCSG Partners Foundation

Terminated

IBCSG Trial 22-00 Serum Substudy

Breast Cancer

Peru, Italy, Nigeria
ETOP IBCSG Partners Foundation

Completed

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (23-01)

Breast Cancer

France, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark
ETOP IBCSG Partners Foundation

Completed

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer (22-00)

Breast Cancer

Italy, Switzerland, Australia, Peru, South Africa, Chile, Belgium, Brazil, Romania, Hungary, Nigeria
ETOP IBCSG Partners Foundation

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer (15-95)

Breast Cancer

Switzerland, Australia
Partners in Internal Medicine

Completed

Patient Understanding of End of Life Care

Advance Directives | Resuscitation Orders

United States
ETOP IBCSG Partners Foundation

Terminated

Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98

Breast Cancer | Osteoporosis
ETOP IBCSG Partners Foundation

Completed

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Breast Cancer | Osteoporosis

France, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa

Clinical Trials Sponsored by Care Partners

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations